Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and immunogenicity of a single-dose adsorbed tetanus vaccine in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Adsorbed Tetanus Vaccine (Tetanus toxoid vaccine, adsorbed)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Tetanus | Phase 3 | Status: COMPLETED